Moving and improving for Omicron
Omicron Research Limited, the UK distributor for CAMAG and Distek Inc., is excited to announce that it will be based in new premises from April 2010.
Located in Hungerford, Berkshire, the modern, fully redecorated building will house the office, warehouse and workshop departments of our scientific equipment distribution and support business. For the first time, Omicron’s complete operation will be housed under one roof, providing a more responsive and streamlined service to customers.
A substantial investment has been made into the refurbishment of the new premises and the upgrade of technology, ensuring continuation of the high level of customer service for which Omicron is renowned. With immediate access to the M4, the new location offers staff and clientele a more convenient and professional environment in which to do business.
To coincide with the move the company hase enhanced its website by adding two new functionalities. An extensive parts catalogue is now available on-line, complemented by a new quotation request facility, providing a fast, easy to use service for customers. We invite you to visit and explore our website, www.omicron-uk.com, where you will find information on an extensive range of dissolution, chromatography, spectroscopy, OPLC and capillary electrophoresis products.
You may also like
Trending Articles
Upcoming event
You may also like
Manufacturing
Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks
Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and
other highly regulated industries
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Finance
Investing in the future of healthcare: from diagnostics innovation to scientific talent pipelines
Strategic UK investment in next-generation cancer diagnostics and cardiovascular research training is accelerating innovation, reducing barriers to adoption and building the multidisciplinary talent needed to deliver long-term improvements in patient outcomes and life sciences growth